Zevra Therapeutics Inc. (ZVRA)
7.67
0.35 (4.78%)
At close: Apr 02, 2025, 3:59 PM
7.48
-2.54%
After-hours: Apr 02, 2025, 07:34 PM EDT
Zevra Therapeutics Ratios Statement
Financials in USD. Fiscal year
is
January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 |
Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 |
PE Ratio | -3.66 | -5.04 | -3.81 | -30.31 | -3.49 | -0.46 | -0.57 | -1.4 | -2.61 | -2.68 | -5.64 | -16.77 | -378.42 |
PEG Ratio | -0.05 | -0.61 | -0.01 | 0.33 | 0.05 | 0.01 | -0.09 | -0.01 | 0.03 | -0.01 | -0.03 | -0.01 | n/a |
PS Ratio | 16.34 | 8.46 | 15.14 | 9.05 | 3.36 | 0.88 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 9.72 | 3.75 | 1.84 | 2.04 | -0.67 | -0.15 | -0.48 | -1.06 | -2.3 | -14.46 | -5.67 | -3.61 | -42.48 |
P/FCF Ratio | -5.54 | -6.86 | -8.42 | 25.08 | -22.61 | -0.47 | -0.59 | -1.83 | -1.42 | -7.17 | -9.36 | -20.01 | -5.98 |
P/OCF Ratio | -5.54 | -6.92 | -8.46 | 24.84 | -22.99 | -0.47 | -0.59 | -1.84 | -1.45 | -7.22 | -9.39 | -20.25 | -6.01 |
OCF/S Ratio | -2.95 | -1.22 | -1.79 | 0.36 | -0.15 | -1.85 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 1.52 | 0.71 | 0.16 | 0.01 | -1.06 | -1.07 | -1.23 | -1.63 | -4.88 | -2.28 | -0.75 | -0.16 | n/a |
Quick Ratio | 2.47 | 0.85 | 7.93 | 27.20 | 1.10 | 1.22 | 1.96 | 4.08 | 11.03 | 6.77 | 2.61 | 0.39 | 2.31 |
Current Ratio | 2.53 | 1.18 | 7.93 | 27.20 | 1.11 | 1.22 | 1.98 | 4.08 | 11.19 | 6.48 | 2.61 | 0.39 | 2.31 |
Asset Turnover | 0.13 | 0.16 | 0.09 | 0.22 | 1.19 | 1.22 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | -11.84 | -33.05 | -74.16 | 20.56 | -0.67 | -3.12 | -7.89 | -4.55 | -5.26 | -8.54 | -6.06 | -30.05 | n/a |
Return on Equity | -2.66 | -0.74 | -0.48 | -0.07 | 0.19 | 0.33 | 0.85 | 0.75 | 0.88 | 5.40 | 1.01 | 0.22 | 0.11 |
Return on Assets | -0.59 | -0.27 | -0.36 | -0.06 | -1.14 | -2.33 | -2.11 | -0.83 | -0.19 | -0.98 | -1.78 | -2.15 | -0.02 |
Return on Invested Capital | -0.7 | -0.36 | -0.23 | 0.06 | -1.05 | -3.79 | -3.05 | -0.75 | -0.48 | -0.45 | -1.55 | -4.42 | -3.99 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 0.69 | 0.89 | 0.97 | 0.93 | 0.90 | 0.77 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | -4.47 | -1.68 | -3.97 | -0.3 | -0.96 | -1.91 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | -3.82 | -1.68 | -4.05 | -0.3 | -0.96 | -1.91 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | -3.68 | -1.81 | -2.38 | 0.27 | -0.36 | -1.58 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | -295.04 | -123.2 | -179.86 | 36.08 | -14.84 | -185.08 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | -3.24 | -1.77 | -2.44 | -0.28 | -0.41 | -1.38 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |